Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 0.25mg dose of Wegovy is not where weight loss happens — it is where your body adjusts. This starting dose is designed to minimise side effects during the first four weeks, not to produce measurable fat loss. Most people lose little or nothing at 0.25mg, and that is entirely expected. A prescriber guides the titration upwards toward the doses where meaningful results occur. These are prescription-only medicines: a clinician assesses whether Wegovy is right for you before any prescription is issued. For context on what Wegovy can achieve across the full course, the picture is considerably more encouraging once you reach the maintenance phase.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, and the honest answer is: at 0.25mg, the goal is tolerability rather than results. Semaglutide (the active medicine in Wegovy) slows gastric emptying and reduces appetite signals via GLP-1 receptors in the gut and brain. At the 0.25mg level, those effects are present but modest. The body is effectively being introduced to the medicine gradually, which reduces the chance of significant nausea or other gastrointestinal side effects during weeks one to four.
Clinical trial data, including the STEP 1 trial published in the New England Journal of Medicine, measured outcomes at the 2.4mg maintenance dose across 68 weeks — not at the starter level. The roughly 15% average body-weight reduction reported in that trial reflects where semaglutide works therapeutically, which is well beyond the initial 0.25mg rung. If you want a detailed look at how much weight loss is realistic on 0.25mg Wegovy, our prescribers walk through what the evidence actually shows at this introductory stage. If you are trying to understand how much weight you will realistically lose on 0.25mg Wegovy, the honest answer is: patience, not pounds, is what this phase is about.
Some people do notice a gentle reduction in appetite even at this dose, and a small number see minor early weight changes. But these are not reliable or consistent, and no prescriber would frame 0.25mg as a weight-loss dose in its own right.
Private Wegovy in the UK is priced per pen, and the starter pen at 0.25mg typically sits at the lower end of the monthly range you will encounter. Reported private prices across providers range roughly from £149 to £375 per month depending on dose and clinic, a range that widened significantly after Eli Lilly's list-price changes in late 2025 (as widely reported in August 2025). If you are keeping an eye on costs, it is worth checking whether a reduced price on Wegovy is available to you before committing to a provider.
What matters, and what headline prices often obscure, is what a given price actually includes. Some providers charge separately for the initial consultation, for the prescription itself, for clinical review before each repeat, and for delivery. A lower monthly figure can become a larger total once those are added. The full cost picture for Wegovy is worth reading carefully before committing to any provider.
At nume, one price covers the consultation, prescription, treatment, and free next-working-day delivery. We are not the cheapest option on the market, and that is deliberate. The difference is in what is built in: a named prescriber reviews your case before every order, not just the first one. There are no subscriptions and no auto-renewals; every repeat involves fresh clinical scrutiny. You can see current treatment pricing on our treatment page.
For a prescription medicine, cost is genuinely the wrong starting point. A low price from an unverified online seller is a warning, not a saving. The MHRA has documented the seizure of approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million, including counterfeit tirzepatide pens found being manufactured in the UK. Fake pens have contained the wrong substances, including insulin in some cases. You can check any online pharmacy on the GPhC register, a legitimate UK pharmacy will be listed there, with a verifiable registration number.
The right questions are: is the medicine coming from the licensed UK supply chain? Is a qualified prescriber reviewing your case? Is there someone you can contact if something does not feel right? The clinical setup at nume is built around those questions. Medicines sourced through Eli Lilly and Novo Nordisk's authorised UK channels, reviewed by a GPhC-registered Independent Prescriber, with seven-day aftercare support included.
The Wegovy overview covers the full licensed picture, including eligibility criteria and how the titration schedule leads to the doses where trials show meaningful results. For a broader sense of what the 2.4mg maintenance dose delivers, the evidence is considerably more compelling than anything 0.25mg alone would suggest. And if you are curious about the step up to 0.5mg, that is where some people begin to notice the medicine settling into a working pattern.
A free consultation with our prescribers is the right next step. Check your eligibility and our clinical team will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.